Overview
Study information
| Network: | GH-VAP |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase III |
| Species: | Human |
| Stage: | Assays Completed |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
The correlate of risk targeted intervention study (CORTIS): A randomized, partially-blinded, clinical trial of isoniazid and rifapentine (3HP) therapy to prevent pulmonary tuberculosis in high-risk individuals identified by a transcriptomic correlate of risk
Description
CORTIS-01 is a clinical trial to evaluate a preventive therapy using isoniazid and rifapentine (3HP) in individuals at high-risk for TB disease identified by transcriptomic-based correlate of risk (COR).
Sign in to see full information about this study and to download study data.
Products
Priftin® INH Vitamin B6Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.